Navigation Links
Cancer experience worse for young adults in spite of better survival odds
Date:11/9/2010

ANN ARBOR, Mich. Younger adult cancer patients have the most difficulty coping with the pain and emotional issues of cancer, in spite of their potentially better survival odds, according to a University of Michigan Health System study.

The study, which included mostly breast and lung cancer patients, appears in the November issue of Pain Medicine, a journal of the American Academy of Pain Medicine.

Adult cancer patients age 40 and under had more pain flares and more difficulty thinking quickly and logically six months after their diagnosis compared to older adults.

Pain also affected their mood more often than adults in their 50s or 60s.

Cancer pain is common, whether it is consistent discomfort or patient flares that interrupt well-controlled pain. International studies suggest nearly 70 percent of people dying from cancer experience unrelieved pain.

"Our study provides evidence for the significant toll of cancer pain on overall health and well-being of young and old adults alike, but demonstrate an increased toll for younger adults, especially financially," says study lead author Carmen R. Green, M.D., a U-M professor of anesthesiology, obstetrics and gynecology, and health management and policy.

In the study, researchers revealed a trend of younger groups having pain in more locations 4.5 locations compared to 2.2 for older adults up to six months after diagnosis.

Older adults reported mostly spinal pain, and younger adults reported pain in the spine, back, arms, abdomen and elsewhere, according to the study.

Young adult cancer patients reported smaller incomes and, perhaps as a result had more difficulty paying health care bills.

In the survey, 75 percent of young patients reported having trouble paying for health care which was twice the rate reported by older adults.

Green, along with co-author Tamera Hart-Johnson, M.S., a senior research associate at U-M, surveyed about 100 patients with advanced stages of breast, lung, colorectal and prostate cancer, and multiple myeloma, a bone marrow cancer.

Among three age groups, the youngest set of those age 40 and younger had the greatest pain interference, but reported improvement over time, according to the study.

For example, 8 percent of young adults said pain affected their mood compared to 4.35 percent of adults in the 41-59 age group, and 4.14 percent among those age 60 and older.

"The groups did not look different mentally or emotionally at the time of diagnosis, although both cognitive functioning and depression worsened for young adults by six months as their treatments and battle with cancer continued," Green says.

The oldest group had better emotional functioning at the start, but by six months had significantly worse physical functioning.

Future studies should attempt to determine how patient age influences patient preferences and attitudes about cancer pain management.

As more people survive cancer, the authors urge that future studies attempt to determine how patient age influences patient preferences and attitudes about cancer pain management.

Additional studies might examine potential differences in support systems, coping strategies, and other factors that may impact overall health, such as caregiving, health insurance and employment, Green says.


'/>"/>

Contact: Shantell M. Kirkendoll
smkirk@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert  

Related medicine news :

1. Combined imaging technologies may better identify cancerous breast lesions
2. New research shows genetic test for lung cancer risk prompts smokers to quit
3. Obesity Not Tied to Breast Cancer Risk in Mexican Americans
4. Smoking May Raise Risk of Death in Women With Breast Cancer
5. Statins Dont Reduce Colon Cancer Risk, Study Finds
6. Massachusetts Institute of Technology IDs new cancer drug target
7. Breast cancer: Reducing the risk of unnecessary chemo
8. Statins did not reduce colorectal cancer in WHI analysis
9. PIT(-1)ting good and bad outcomes against each other in breast cancer
10. Hebrew University researchers discover expanded role for cancer-causing gene
11. Joint pain linked to breast cancer drug not inflammatory arthritis or autoimmune disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer experience worse for young adults in spite of better survival odds
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: